AI & Technology

Andy York

30 Years in Pharma Programming, AI Guardrails & the Future of Statistical Programming

Today's guest is Andy York, one of the most respected voices in global statistical programming and clinical data science. Andy shares 30+ years of lessons — from paper CRFs to AI guardrails, the shift from SAS to R, and what the next generation of pharma programmers must learn to stay relevant.

Bilal Bham

Life Sciences Strategy, Human Perspective & Building Amodaia

Today's guest is Bilal Bham, founder and CEO of Amodaia, a senior-led life science consultancy supporting biotech, pharma, and medtech teams at critical decision points across regulatory affairs, medical affairs, market access, marketing communications, and fundraising. With nearly two decades in life sciences, Bilal brings both strategic clarity and a human perspective shaped by lived experience.

Steven Thompson

AI, Clinical Trial Activation & Why 85% of Trials Are Delayed

Today's guest is Steven Thompson, who spent more than two decades reshaping how clinical research actually gets done. He's the founder of Next trial AI and a leading voice at the intersection of AI trial activation and human-centered design in healthcare.

Scott Schliebner

DCTs, Patient-Centric Trials & 30 Years of Pharma Innovation

Today's guest is Scott Schliebner, who is a seasoned biopharma executive with nearly 30 years of experience spanning biotech, CROs and nonprofit life science organizations. He currently serves as CEO and founder of Ascent Biostrategies and previously has worked at Novatech and various other companies.

Thibault Geoui

AI, Drug Discovery What Next Generation of Scientists Must Learn

Today's guest is Thibault Geoui, dr. Tebo z, host of the acclaimed Tech and Drugs podcast, and a driving force at the intersection of biotech innovation and digital transformation. His podcast has become a go-to platform for unpacking the future of pharma, where Thibault brings a rare blend of scientific insight and startup savvy.

Poorya Amini

Protocol AI, 800k Clinical Trials & Why Pharma Does It Wrong

Today's guest is Poorya Amini, founder and CEO of Risklick A Swiss digital health company that's redefining how clinical trial protocols are designed Poorya's, journey spans veterinary medicine, a PhD in pharmacology. And hands-on experience managing trials at the University of Burn.

Matt Veatch

Real World Data, Phenotypes & Why Precision Beats Big Data

Today's guest is Matt Veatch, co-founder and COO of Naviance, and a driving force behind the Real World Wednesday's podcast, a weekly forum that's shaping how we think about real world data and real world evidence.

Dr Andrée Bates

Pharma AI, Saving Lives with Data & the HelloFresh of Medicine

Today's guest is Dr Andree Bates, who is a pioneering force in pharmaceutical ai. She's known for transforming how life science companies harness data to drive growth, innovation, and patient outcomes. As founder and CEO of Eularis, Dr.

Sverre Bengtsson

Building Viedoc, the Airport Deal & Why Europe Must Work Together

Today's guest is Sverre Bengtsson, who is a trailblazer in clinical trial innovation and digital transformation. As co-founder at Viedoc Technologies, he's helped shape one of the most widely adopted eClinical platforms in the world, streamlining trials across more than 80 countries, and empowering thousands of research teams to work smarter and faster.

Wessam Sonbol

From Personal Struggle to Global Impact

Today's guest is Wessam Sonbol, CEO of Delve Health, a pioneering force in digital health and decentralized trials. Leading a groundbreaking platform that supports clinical research in 65+ languages, Wessam is revolutionizing patient access to clinical trials through innovative integration of wearables, telehealth, and AI-powered solutions.

Anders Mortin

TriTiCon: Humanizing Biometrics Data

Today's guest is Anders Mortin, who is a seasoned eClinical professional with over two decades of experience in clinical development processes and systems known for his strategic vision and leadership, Anders excels in managing cross-functional teams and driving innovative solutions.